Midwall Fibrosis: Cardiac Magnetic Resonance Imaging in Risk Stratifying Cardiomyopathies
D.P. Ripley1 , 2 , *
P. Garg3
A. Kotecha1
O.E. Gosling1 , 2
N.G. Bellenger1 , 2
Authors Info & Affiliations
P. Garg3
A. Kotecha1
O.E. Gosling1 , 2
N.G. Bellenger1 , 2
Authors Info & Affiliations
The Open Cardiovascular Medicine Journal
•
30 Oct 2015 •
RESEARCH ARTICLE
•
DOI: 10.2174/1874192401509010089
Abstract
The United Kingdom’s National Institute for Health and Care Excellence guidance on implantable cardiac defibrillator (ICD) therapy recommend ICD in those with left ventricular dysfunction and a high risk of sudden cardiac death (SCD). SCD accounts for 30% deaths in non-ischaemic dilated cardiomyopathy (DCM), however risk stratifying and predicting SCD in DCM is a major management challenge. We present two cases demonstrating the potential role of cardiac magnetic resonance imaging in risk stratifying DCM.
Keywords: Magnetic Resonance Imaging, Sudden Cardiac Death, Ventricular Tachycardia, Dilated Cardiomyopathy, Fibrosis.
